Respiratory Care Devices Market: Therapeutic devices (PAP Devices), Monitoring devices (Pulse Oximeters), Diagnostic devices (Spirometers), Accessories & Consumables (Disposable Masks), and Application (Asthma and Others)- Forecast till 2030

Respiratory Care Devices Market Overview The Respiratory Care Devices Market is anticipated to reach USD 19.84 Billion by 2030 at 8.60% CAGR during the forecast period 2022-2030. Patients with cardiopulmonary devices are treated, assessed, diagnosed, and cared for using respiratory care equipment. There are lung disorders such as chronic bronchitis, TB, acute and chronic pulmonary diseases, asthma, and others that are treated with respiratory care devices. As people get older, the function of their lungs begins to deteriorate, causing physiological, functional, and immunological alterations in the respiratory system. Chronic pulmonary illnesses, asthma, and other respiratory ailments are on the rise, fueling market expansion. The gadgets, which have evolved from stationary to portable, can be employed in hospitals and in-home care settings. The most recent and serious of these disorders is COVID-19, which has resulted in a surge in demand for personal protective equipment and ventilators, among other things. The market is expected to increase due to factors such as the rising prevalence of respiratory disorders, the growing geriatric population, urbanization and its negative consequences, and changes in the environment and lifestyle. The rising need for point-of-care diagnostic devices in developing countries is expected to open up new prospects for respiratory care device manufacturers. Because of the COVID-19 outbreak, demand for ventilators has increased, leading to government and industry support to accelerate production. As a result of the increased focus on respiratory treatment in the context of an outbreak, the market is likely to develop at a strong rate.

Segmentation

The respiratory care devices market has been segmented on the basis of therapeutic devices, monitoring devices, diagnostic devices, accessories and consumables, application, and end-users.

On the basis of therapeutic devices, the market has been classified as pap devices, masks, ventilators, nebulizers, humidifiers, oxygen concentrators, inhalers, reusable resuscitators, nitric oxide delivery units, and oxygen hoods.

On the basis of monitoring devices, the market has been classified as pulse oximeters, pulse oximeter sensors, pulse oximeter equipment, capnographs, and gas analyzers.

On the basis of diagnostic devices, the market has been classified as spirometers, polysomnography (PSG) devices, peak flow meters, and other diagnostic devices.

On the basis of accessories and consumables, the market has been classified as disposable masks, disposable resuscitators, tracheostomy tubes, nasal cannulas, and other consumables and accessories.

On the basis of application, the market has been classified as chronic obstructive pulmonary disease (COPD), sleep apnea, asthma, infectious diseases, and other diseases.

On the basis of end-users, the market has been classified as hospitals, clinics, ambulatory care, home care, and others.

On the basis of region, the market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. The Americas has been further segmented into North America and South America, with the North American market divided into the US and Canada.

The European respiratory care devices market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The respiratory care devices market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The respiratory care devices market in the Middle East and Africa has been segmented into the Middle East and Africa.

Regional Market Summary

Global Respiratory Care Devices Market Share, by Region, 2017 (%)

Source: MRFR Analysis

In the respiratory care devices market, North America is anticipated to account for the largest market share due to the early adoption of advanced medical technologies, the rise in awareness, the rise in growth of the healthcare sector, and due to favorable compensation setting for many surgical procedures. According to the Centers for Disease Control and Prevention, in 2015, the number of deaths due to chronic lower respiratory diseases (including asthma) in the US were 155,041 and the number of adults diagnosed with chronic bronchitis was 8.9 million.

The European market is expected to hold the second largest market share. The market growth in this region can be attributed to the rising frequency of diabetic patients, an increasing number of surgeries, and the increasing demand for advanced treatment procedures. According to Eurostat statistics in 2014, there were nearly 382 thousand deaths in the European Union due to respiratory diseases. According to the Global Status Report on Non-Communicable Diseases, 2010 by the World Health Organization (WHO), smoking is predicted to cause about 71% of all lung cancer deaths and 42% of chronic respiratory diseases worldwide.

The Asia-Pacific market is expected to be the fastest growing segment in the near future due to the most dominant causes of respiratory illness and mortality that include tobacco smoking, infections, and air pollution. Factors such as access to optimal treatment facilities, better adoption rate, increase in disposable income, and rising medical tourism help to boost the fastest growing region. The government and NGO's are taking numerous initiatives to spread public awareness and control of the environment regarding the prevention and treatment of respiratory diseases.

The market in the Middle East and Africa is expected to account for the smallest share of the global respiratory care devices market due to an underdeveloped healthcare sector, lack of technical knowledge, and poor medical facilities.

Key Players

Some of the key players in the global respiratory care devices market are Philips Healthcare (Netherlands), ResMed, Inc. (US), Medtronic plc (Ireland), Masimo Corporation (US), and Fisher & Paykel Healthcare Corporation Limited (New Zealand), Becton, Dickinson and Company (US), Chart Industries, Inc. (US), Drägerwerk AG & Co. KGaA (Germany), and Hamilton Medical AG (Switzerland).

Respiratory Care Devices Market, by Therapeutic Devices

• Pap devices


• Masks


• Ventilators


• Nebulizers


• Humidifiers


• Oxygen concentrators


• Inhalers


• Reusable resuscitators


• Nitric oxide delivery units


• Oxygen hoods

Respiratory Care Devices Market, by Monitoring Devices

• Pulse oximeters


• Pulse oximeter sensors


• Pulse oximeter equipment


• Capnographs


• Gas analyzers

Respiratory Care Devices Market, by Diagnostic Devices

• Spirometers


• Polysomnography (PSG) Devices


• Peak Flow Meters


• Other Diagnostic Devices

Respiratory Care Devices Market, by Accessories and Consumables

• Disposable masks


• Disposable resuscitators


• Tracheostomy tubes


• Nasal cannulas


• Other consumables and accessories

Respiratory Care Devices Market, by Application

• Chronic obstructive pulmonary disease (COPD)


• Sleep apnea


• Asthma


• Infectious diseases


• Other diseases

Respiratory Care Devices Market, by End-Users

• Hospitals


• Clinics


• Ambulatory care


• Home care 


• Others

Respiratory Care Devices Market, by Region

• North America


• US


• Canada


• South America

• Western Europe


• Germany


• France


• Italy


• Spain


• UK


• Rest of Western Europe


• Eastern Europe

• Japan


• China


• India


• Australia


• South Korea


• Rest of Asia-Pacific

• Middle East


• Africa

Recent Development

Intended Audience

• Respiratory care device manufacturers and distributors


• Healthcare institutions (hospitals, laboratories, medical schools, and outpatient clinics)


• Research institutes


• Contract manufacturing organizations (CMOs)


• Government associations


• Market research and consulting firms


• Venture capitalists and investors